Tech Company Financing Transactions

PanOptica Funding Round

PanOptica, based in Bernardsville, secured $45 million from Novo Ventures, Third Rock Ventures and SV Health Investors.

Transaction Overview

Company Name
PanOptica
Announced On
4/15/2014
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Thomas Dyrberg)

Third Rock Ventures (Lead Investor) (Kevin Starr)

SV Health Investors (Lutz Giebel)

Proceeds Purpose
Proceeds will be used to fund the clinical program for its lead compound, PAN-90806, a pharmacologically unique small-molecule selective inhibitor of VEGF (vascular endothelial growth factor) signaling being investigated as a topical (eye drop) treatment for neovascular age-related macular degeneration (neovascular AMD).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
150 Morristown Rd. 205
Bernardsville, NJ 07924
USA
Phone
(908) 766-2202
Website
www.panopticapharma.com
Email Address
[email protected]
Overview
PanOptica is a biotechnology company specializing in new treatments for diseases of the eye. The company is looking for differentiable candidates against well-characterized targets with credible clinical/regulatory paths to registration.
Profile
PanOptica LinkedIn Company Profile
Social Media
PanOptica Company Twitter Account
Company News
PanOptica News
Facebook
PanOptica on Facebook
YouTube
PanOptica on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Chaney
  Paul Chaney LinkedIn Profile  Paul Chaney Twitter Account  Paul Chaney News  Paul Chaney on Facebook
Chief Medical Officer
Martin Wax
  Martin Wax LinkedIn Profile  Martin Wax Twitter Account  Martin Wax News  Martin Wax on Facebook
VP - Bus. Development
David Bingaman
  David Bingaman LinkedIn Profile  David Bingaman Twitter Account  David Bingaman News  David Bingaman on Facebook
VP - Finance
Lori Forrest
  Lori Forrest LinkedIn Profile  Lori Forrest Twitter Account  Lori Forrest News  Lori Forrest on Facebook
VP - Operations
Kristine Curtiss
  Kristine Curtiss LinkedIn Profile  Kristine Curtiss Twitter Account  Kristine Curtiss News  Kristine Curtiss on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/15/2014: Bass Manager venture capital transaction
Next: 4/15/2014: VanDyne SuperTurbo venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.